Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

Author： Wilson S.H. Kennedy F.P. Garratt K.N.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.5, 2001-01, pp. : 325-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E. denver A.E. Mohamed-Ali V. Yudkin J.S.

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus Cardiovasc

By Manfredi Samantha Calvi Debora del Fiandra Martina Botto Nicoletta Biagini Andrea Andreassi Maria Grazia

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 29-34

Future Medicine

Access to resources Recommend Favorite

Preventing Macrovascular Disease in Patients with Type 2 Diabetes Mellitus

By Johansen O.E.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Use of medications for cardiovascular disease and type 2 diabetes mellitus is reduced after bariatric surgery for weight management in patients with severe obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3802-3816

Bentham Science Publishers

Access to resources Recommend Favorite